AvatarInvesting.com Australiaflipped into Australia Financial MarketsAvatarAvatarNektar Therapeutics secures $30 million in private financingInvesting.com AustraliaSAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company specializing in the treatment of auto-immune disorders, has announced …
AvatarTipRanksflipped into The LatestFlipboardIcon version of the Flipboard logoOptions Volatility and Implied Earnings Moves Today, March 04, 2024tipranks.com - TipRanks NewsdeskToday, several major companies are expected to report earnings: AeroVironment (AVAV), Avadel Pharmaceuticals (AVDL), Global Ship Lease (GSL), Nektar …
AvatarInvesting.com Australiaflipped into Australia Financial MarketsAvatarAvatarEarnings call: Nektar Therapeutics unveils drug development progressInvesting.com AustraliaNektar Therapeutics (NASDAQ: NASDAQ:NKTR) has recently shared updates on its drug development pipeline during its Fourth Quarter 2023 Financial …
AvatarSeeking Alphaflipped into Breaking NewsAvatarAvatarNektar Therapeutics GAAP EPS of -$0.22 misses by $0.01, revenue of $23.89M beats by $2.52Mverified_publisherSeeking Alpha - Pranav Ghumatkar• Nektar Therapeutics press release (NASDAQ:NKTR): Q4 GAAP EPS of -$0.22 misses by $0.01. • Revenue of $23.89M (+8.5% Y/Y) beats by $2.52M. • Cash and …
AvatarPeak Bggrflipped into Biotech InvestingAvatarAvatarNektar Therapeutics enters into a $30M private placement financing agreementverified_publisherSeeking Alpha - Sinchita Mitra• Nektar Therapeutics (NASDAQ:NKTR) said it has entered into a securities purchase agreement with TCGX, to sell securities in a private placement …
AvatarSeeking AlphaAvatarAvatarMar 3Nektar Therapeutics Q4 2023 Earnings Previewverified_publisherSeeking Alpha - Pranav Ghumatkar• Nektar Therapeutics (NASDAQ:NKTR) is scheduled to announce Q4 earnings results on Monday, March 4th, after market close. • The consensus EPS Estimate is …